Shares of biotech specialist Regeneron Pharmaceuticals (REGN), which have surged 68% year to date, have been a popular way to play the race for a COVID-19 treatment.
The agenda for investors today is pretty much the same as it was yesterday - gridlock in Washington over the next round of pandemic related stimulus, a plethora of corporate earnings, and more.
With the COVID-19 crisis curtailing on-site sales meetings and networking at conferences, asset managers of all sizes have been scrambling to produce more digital content for consumption at home by their clients and prospects.
USD/JPY recently broke through ¥105 and started trading toward ¥104. That set off familiar alarm bells in Tokyo and the usual warnings from officials that I’ve been hearing for decades now.
USD/JPY recently broke through ¥105 and started trading toward ¥104. That set off familiar alarm bells in Tokyo and the usual warnings from officials that I’ve been hearing for decades now.
USD/JPY recently broke through ¥105 and started trading toward ¥104. That set off familiar alarm bells in Tokyo and the usual warnings from officials that I’ve been hearing for decades now.
In late July 2020, the U.S. Health Department confirmed that a blockchain program to track information related to COVID-19 is operational and in use, marking a significant new use case for distributed ledger technology.
Today, we speak with Austin Roberts, an intern on the Index Portfolio Management Team from The University of Central Florida. Roberts is a rising senior majoring in Finance and minoring in Computer Science.
Can last week's gains hold this week if there are no signs of progress that Congress and the White House can agree on the next round of the pandemic relief bill? Plus: Here are the key earnings to watch this week